DYADIC INTERNATIONAL INC Increase (Decrease) in Accounts Payable
DYADIC INTERNATIONAL INC (DYAI) reported Increase (Decrease) in Accounts Payable of -$28.44 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$251.13K, a 194.18% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $222.70K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$367.10K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $457.47K, a 298.21% increase year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for fiscal 2025 was $314.45K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for fiscal 2024 was -$180.18K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for fiscal 2023 was -$651.17K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts payable for fiscal 2022 was -$248.13K, a 145.15% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$251.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$28.44K 10-Q · filed 2026-08-12 | -$395.53K derived: sum of 3 quarters · filed 2026-08-12 | $61.93K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $222.70K 10-Q · filed 2026-05-13 | -$144.40K derived: sum of 2 quarters · filed 2026-05-13 | $313.07K derived: sum of 3 quarters · filed 2026-05-13 | $579.73K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$367.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $90.37K derived: sum of 2 quarters · filed 2026-03-25 | $357.04K derived: sum of 3 quarters · filed 2026-08-12 | $314.45K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $457.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $724.13K derived: sum of 2 quarters · filed 2026-08-12 | $681.55K 10-Q · filed 2025-11-12 | $610.79K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $266.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $224.08K 10-Q · filed 2026-08-12 | $153.32K derived: sum of 3 quarters · filed 2026-08-12 | $268.20K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$42.59K 10-Q · filed 2026-05-13 | -$113.34K derived: sum of 2 quarters · filed 2026-05-13 | $1.54K derived: sum of 3 quarters · filed 2026-05-13 | -$227.97K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$70.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $44.13K derived: sum of 2 quarters · filed 2026-03-25 | -$185.38K derived: sum of 3 quarters · filed 2026-03-25 | -$180.18K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $114.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$114.63K derived: sum of 2 quarters · filed 2025-11-12 | -$109.43K 10-Q · filed 2025-11-12 | -$69.12K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$229.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$224.31K 10-Q · filed 2025-08-13 | -$184.00K derived: sum of 3 quarters · filed 2025-08-13 | -$470.67K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $5.20K 10-Q · filed 2025-05-14 | $45.50K derived: sum of 2 quarters · filed 2025-05-14 | -$241.17K derived: sum of 3 quarters · filed 2025-05-14 | -$119.41K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $40.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$246.37K derived: sum of 2 quarters · filed 2025-03-26 | -$124.61K derived: sum of 3 quarters · filed 2025-03-26 | -$651.17K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$286.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$164.91K derived: sum of 2 quarters · filed 2024-11-12 | -$691.47K 10-Q · filed 2024-11-12 | -$222.63K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $121.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$404.80K 10-Q · filed 2024-08-13 | $64.03K derived: sum of 3 quarters · filed 2024-08-13 | -$222.03K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$526.56K 10-Q · filed 2024-05-14 | -$57.72K derived: sum of 2 quarters · filed 2024-05-14 | -$343.79K derived: sum of 3 quarters · filed 2024-05-14 | -$94.77K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $468.84K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $182.77K derived: sum of 2 quarters · filed 2024-03-28 | $431.79K derived: sum of 3 quarters · filed 2024-03-28 | -$248.13K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$286.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$37.05K derived: sum of 2 quarters · filed 2023-11-08 | -$716.96K 10-Q · filed 2023-11-08 | -$120.37K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $249.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$430.90K 10-Q · filed 2023-08-09 | $165.70K derived: sum of 3 quarters · filed 2023-08-09 | -$1.31M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$679.92K 10-Q · filed 2023-05-10 | -$679.92M 10-Q · filed 2022-05-12 | -$83.32K derived: sum of 2 quarters · filed 2023-05-10 | -$1.56M derived: sum of 3 quarters · filed 2023-05-10 | -$480.59M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $596.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$878.25K derived: sum of 2 quarters · filed 2023-03-29 | -$479.91M derived: sum of 3 quarters · filed 2023-03-29 | $549.56K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$480.50M derived: sum of 2 quarters · filed 2022-11-10 | -$47.03K 10-Q · filed 2022-11-10 | -$38.58K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$479.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.43M 10-Q · filed 2022-08-10 | $1.44M derived: sum of 3 quarters · filed 2022-08-10 | $1.22M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $480.45M 10-Q · filed 2022-05-12 | $480.45K 10-Q · filed 2021-05-13 | $480.46M derived: sum of 2 quarters · filed 2022-05-12 | $480.25M derived: sum of 3 quarters · filed 2022-05-12 | $480.69M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $8.45K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$207.68K derived: sum of 2 quarters · filed 2022-03-29 | $239.16K derived: sum of 3 quarters · filed 2022-03-29 | -$53.20K 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$216.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $230.71K derived: sum of 2 quarters · filed 2021-11-10 | -$61.65K 10-Q · filed 2021-11-10 | $166.05K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $446.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $154.48K 10-Q · filed 2021-08-12 | $382.19K derived: sum of 3 quarters · filed 2021-08-12 | $147.02K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$292.36K 10-Q · filed 2021-05-13 | -$64.66K derived: sum of 2 quarters · filed 2021-05-13 | -$299.83K derived: sum of 3 quarters · filed 2021-05-13 | -$276.50K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $227.70K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$7.47K derived: sum of 2 quarters · filed 2021-03-30 | $15.86K derived: sum of 3 quarters · filed 2021-03-30 | $657.66K 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$235.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$211.84K derived: sum of 2 quarters · filed 2020-11-12 | $429.95K 10-Q · filed 2020-11-12 | $198.85K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $23.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $665.13K 10-Q · filed 2020-08-13 | $434.03K derived: sum of 3 quarters · filed 2020-08-13 | $745.12K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $641.80K 10-Q · filed 2020-05-14 | $410.70K derived: sum of 2 quarters · filed 2020-05-14 | $721.79K derived: sum of 3 quarters · filed 2020-05-14 | $503.08K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$231.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $79.99K derived: sum of 2 quarters · filed 2020-03-30 | -$138.72K derived: sum of 3 quarters · filed 2020-03-30 | -$195.75K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $311.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $92.38K derived: sum of 2 quarters · filed 2019-11-13 | $35.34K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$218.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$275.75K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$57.04K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $207.43K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |